OFI Advisors’s Emergent Biosolutions EBS Stock Holding History

OFI Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$225K	Sell	7,899 -480	-6%	-$15.8K	0.01%	1155
2015 Q2	$276K	Buy	8,379 +72	+0.9%	+$2.23K	0.02%	1084
2015 Q1	$239K	Buy	8,307 +855	+11%	+$24.5K	0.01%	1156
2014 Q4	$203K	Buy	7,452 +172	+2%	+$4.1K	0.01%	1196
2014 Q3	$155K	Buy	7,280 +692	+11%	+$15.8K	0.01%	1279
2014 Q2	$148K	Buy	6,588 +1,595	+32%	+$37.1K	0.01%	1309
2014 Q1	$126K	Sell	4,993 -504	-9%	-$12.7K	0.01%	1341
2013 Q4	$126K	Buy	5,497 +517	+10%	+$10.8K	0.01%	1317
2013 Q3	$95K	Sell	4,980 -60	-1%	-$1.07K	0.01%	1351
2013 Q2	$73K	Buy	+5,040	New	+$73K	0.01%	1402

Other funds holding EBS

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OFI Advisors's EBS Position: Q3 2015 in Review

OFI Advisors reduced its Emergent Biosolutions (EBS) stake by 5.7% in Q3 2015, selling an estimated $15.8K and leaving 7,899 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #1155.

OFI Advisors first reported a position in EBS in Q2 2013 and has held it in 10 quarters since. The position peaked at $276K in Q2 2015. 199 funds tracked by Wall St. Rank hold EBS as of Q3 2015.

OFI Advisors held 7,899 shares of Emergent Biosolutions worth $225K as of Q3 2015.
OFI Advisors sold 480 Emergent Biosolutions shares in Q3 2015, an estimated $15.8K.
Emergent Biosolutions made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1155 holding.
OFI Advisors first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Emergent Biosolutions position peaked at $276K in Q2 2015.
199 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.